Enovix Corporation Common Stock
Here’s whether Enovix Corporation Common Stock (ENVX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: 50-day MA is rising (+7.72% over 10 days); RSI 50 — healthy momentum range; 3-month momentum positive (+31.4%). Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); weak 1-year return of -12.0%. Currently 59.6% off its 52-week high. Score: -1/7.
ENVX is trading below its 200-day MA ($7.86) — a key warning sign the longer-term trend is under pressure. An RSI of 49.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -12.0% compares to +22.9% for SPY (trailed the market by 34.9%). The current 59.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.